Statins Cause Muscle Pain in Less Than 10% of Patients

August 30, 2022 by Dan McCue
Statins Cause Muscle Pain in Less Than 10% of Patients
This June 14, 2011, file photo, shows the pills of the drug Lipitor in Willingboro, N.J. (AP Photo/Matt Rourke, File)

BARCELONA, Spain — Statins have long been seen as an important intervention in preventing serious cardiovascular episodes, but many patients stop taking them over time because of side effects like digestive issues, sleep disruptions and muscle pain.

However, a study presented this week at the European Society of Cardiology Congress in Spain suggests that for more than 90% of patients on statins who experience muscle pain, the statins are not the cause.

In fact, according to the study which was published in The Lancet, while statin therapy has been found to produce a 7% relative increase in muscle pain or weakness, the researchers found no significant increase after that.

Their findings are consistent with other studies that have shown that less than 10% of people have muscle-related symptoms like muscle aches that seem to be associated with taking a statin.

“Our results confirm that, in the majority of cases, statin therapy is not likely to be the cause of muscle pain in a person taking statin therapy,” the study says. “This finding is particularly true if the treatment has been well tolerated for a year or more before developing symptoms.”

The study was conducted by researchers from Oxford Population Health and the Medical Research Council Population Health Research Unit at the University of Oxford in the United Kingdom.

Over the course of their research, the authors conducted a meta-analysis — a statistical analysis that combines the results of multiple scientific studies — of 19 randomized double-blind trials of statin regimens versus placebos. 

All trials had over 1,000 participants and at least two years of follow-up. 

They also looked at an additional four double-blind trials of more and less intense statin regimens.

The authors said in the trials they looked at, statin therapy caused approximately 11 additional muscle pain reports per 1,000 patients in the first year of use.

They said this finding suggests medical practitioners need to do a better job of managing patients’ pain so that they don’t forgo statins and suffer worse impacts to their long term health.

In addition, they said the profession — and drug manufacturers — need to take a closer look at the information about things like muscle pain that is available to patients in the package inserts they receive with their medication.

According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for men, women and people of most racial and ethnic groups in the United States. 

There is one cardiovascular disease death every 34 seconds in the country, the CDC says.

Dan can be reached at [email protected] and at https://twitter.com/DanMcCue.

A+
a-
  • cardiovascular
  • muscle pain
  • pain management
  • Statins
  • treatment
  • In The News

    Health

    Voting

    Health

    What Do Weight Loss Drugs Mean for a Diet Industry Built on Eating Less and Exercising More?

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds... Read More

    NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept... Read More

    April 24, 2024
    by Dan McCue
    First Lady Jill Biden Salutes ‘The Power of Research’ at DC Symposium

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished... Read More

    WASHINGTON — Even years after the fact, First Lady Dr. Jill Biden recalled the moment with a sense of astonished disbelief. Biden was second lady, the wife of Vice President Joe Biden, at the time, and Maria Shriver was the first lady of California.  Both were... Read More

    April 24, 2024
    by Dan McCue
    FDA Approves New Treatment for Urinary Tract Infections

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary... Read More

    WASHINGTON — The Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections.  “Uncomplicated UTIs are a very common condition impacting women and one of the most frequent reasons for antibiotic use,” said Dr. Peter Kim, M.S.,... Read More

    When Red-Hot Isn't Enough: New Heat Risk Tool Sets Magenta as Most Dangerous Level

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to... Read More

    WASHINGTON (AP) — Forget about red hot. A new color-coded heat warning system relies on magenta to alert Americans to the most dangerous conditions they may see this summer. The National Weather Service and the Centers for Disease Control and Prevention on Monday — Earth Day... Read More

    April 23, 2024
    by Dan McCue
    President Lays Out New Steps for Protecting Nation’s Waters

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’... Read More

    WASHINGTON — The Biden administration on Tuesday set out a new national goal for conserving and restoring the United States’ freshwater resources, including 8 million acres of wetlands and 100,000 miles of rivers and streams. Officials unveiled the plan as state, tribal and local leaders from... Read More

    April 23, 2024
    by Beth McCue
    Study Finds Next-Gen Antibiotics Underutilized

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat... Read More

    WASHINGTON — A new study conducted by researchers at the National Institutes of Health found clinicians frequently continue to treat antibiotic-resistant infections with older generic antibiotics considered to be less effective and less safe than newer ones. Researchers examined the factors influencing doctors’ preference for older... Read More

    News From The Well
    scroll top